Immunotherapy for urothelial cancer: from the diagnostic pathologist’s point of view

Alessia Cimadamore, Marina Scarpelli, Francesco Massari, Markus Eckstein, Thomas Gevaert, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)539-544
Number of pages6
JournalExpert Opinion on Biological Therapy
Volume20
Issue number6
DOIs
StatePublished - Jun 2 2020

Keywords

  • Bladder cancer
  • PD-L1
  • PD-L1 testing
  • immunohistochemistry
  • immunotherapy

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Cimadamore, A., Scarpelli, M., Massari, F., Eckstein, M., Gevaert, T., Cheng, L., Lopez-Beltran, A., & Montironi, R. (2020). Immunotherapy for urothelial cancer: from the diagnostic pathologist’s point of view. Expert Opinion on Biological Therapy, 20(6), 539-544. https://doi.org/10.1080/14712598.2020.1733965